SHARE-BASED COMPENSATION (Tables)

3 Months Ended

Feb. 02, 2025

SHARE-BASED COMPENSATION [Abstract]

Share-based Compensation Expenses

The table below presents information on the Company’s share-based compensation expenses.

	Three Months Ended
	February 2, 2025		January 28, 2024
Expense reported in:
Cost of goods sold	$	776	$	595
Selling, general, and administrative		2,268		1,749
Research and development		290		229
Total expense incurred	$	3,334	$	2,573
Expense by award type:
Restricted stock awards	$	3,277	$	2,573
Employee stock purchase plan		57		-
Total expense incurred	$	3,334	$	2,573
Income tax benefits on share-based compensation	$	446	$	99

Restricted Stock Awards Activity

The table below presents information on the Company’s restricted stock awards.

	Three Months Ended
	February 2, 2025		January 28, 2024
Number of shares granted in period		345,500		825,050
Weighted-average grant-date fair value of awards (in dollars per share)	$	23.82	$	29.77
Compensation cost not yet recognized	$	25,786	$	31,426
Weighted-average amortization period for cost not yet recognized (in years)		3.0		3.3
Shares outstanding at balance sheet date		1,256,697		1,634,315

Stock Options Activity

The table below presents information on the Company’s stock options.

	Three Months Ended
	February 2, 2025		January 28, 2024
Number of options granted in period		-		-
Cash received from options exercised	$	1,272	$	936
Compensation cost not yet recognized	$	-	$	-
Weighted-average amortization period for cost not yet recognized (in years)		-		-

Outstanding and Exercisable Option

Information regarding outstanding and exercisable option awards as of February 2, 2025, is presented below.

Options	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value
Outstanding and exercisable at February 2, 2025		150,325	$	10.73		2.05	$	1,843